In a second non-linear screen, additional excipients from several

In a second non-linear screen, additional excipients from several new classes (including antioxidants, chelating agents, and surfactants) were tested (Fig. 3b). High performers included sodium gluconate and xylitol, which were then included in the design of Phase IV. Both positive (e.g. sodium gluconate) and negative (Tween 20 and Tween 80) concentration effects were observed. At higher concentrations, Tween likely shifts from behaving like a stabilizer to becoming a detergent, causing disruption of the virion lipid envelope. Likewise, non-polar amino acids were better performers than other classes of amino acids, but the reasons for this are

unclear. In Stage IV (18 variables, 3200 unique formulations), higher order formulations (5–8 excipients) including promising buffer/stabilizer combinations were combined with antioxidants and chelating agents. The same excipients continued to perform well, including citrate pH 6.0, gelatin, trehalose, and LEE011 molecular weight valine. Bleomycin nmr Finally, in Stage V (25 variables, 1280 unique formulations), a limited concentration optimization of 22 high performing formulations showed that for most excipients stability decreased as concentrations increased. Interestingly,

ionic components including, MgSO4 and MgCl2[34], have been shown to affect the stability of the MV. Both xylitol and sodium gluconate have been shown to bind to Ca2+[35], suggesting one potential mechanism for the stabilization effect. Fig. 3c graphically depicts the linear screening strategy by focusing on

the progression of formulations tested through all five stages that led to a single high-performing final candidate formulation, starting with citrate 50 mM (pH 7.4) in Stage I and building incrementally to a partially concentration optimized formulation of citrate Florfenicol 50 mM (pH 6.0), gelatin, trehalose, sucrose, asparagine, and glycine (Formulation C in Table 2) in Stage V. In order to confirm “hits” identified during HT screening, a suite of validation assays were applied following completion of each screening stage (the final validated formulations are described in Table 2). In the HT assay, the viral inoculum added to cells contains residual, diluted formulation from thermal challenge which could render cells more permissive to infection, and therefore cause an artificial increase in object counts independent from thermal stabilization of virus. All of the high-performing formulations were confirmed to be not acting through this trivial mechanism (data not shown). In accelerated degradation studies over 8 h at 40 °C, formulations based on citrate and tricine demonstrated superior stabilizing effects (Fig. 4a) relative to those in a potassium phosphate background (data not shown). It is possible that sodium citrate has a slight deaggregating effect on virus (thereby giving rise to an apparent increase in viral titer) as opposed to a strictly protective effect, as suggested from studies with rotavirus vaccine [36].

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>